university of north carolina at chapel hill

(University of North Carolina at Chapel Hill) Scientists at the University of North Carolina at Chapel Hill have learned to customize a key human enzyme responsible for producing heparin, opening the door to a more effective synthetic anticoagulant as well as treatments for other conditions.

(Vanderbilt University Medical Center) To understand how the virus that caused SARS -- severe acute respiratory syndrome -- may have jumped from bats to humans, a team of investigators from Vanderbilt University Medical Center and the University of North Carolina at Chapel Hill has generated a synthetic SARS-like bat coronavirus.

The virus -- the largest replicating synthetic organism ever made -- is infectious in cultured cells and mice, the researchers report in the Proceedings of the National Academy of Sciences.

(University of North Carolina at Chapel Hill) Two University of North Carolina at Chapel Hill faculty members have been elected to the Institute of Medicine, considered one of the nation's highest honors for those in the fields of health and medicine.

(University of North Carolina at Chapel Hill) The University of North Carolina at Chapel Hill School of Public Health has established a new Gillings Innovation Lab to track and map tropical infectious diseases such as malaria, using state-of-the-art molecular and demographic methods.

(University of North Carolina School of Medicine) University of North Carolina at Chapel Hill researchers have demonstrated that a drug called ondansetron helps reduce vomiting, the need for intravenous fluids and hospital admissions in children with acute gastroenteritis.

(University of North Carolina at Chapel Hill) In the budding field of nanotechnology, scientists already know that size does matter.

But now, researchers at the University of North Carolina at Chapel Hill have shown that shape matters even more -- a finding that could lead to new and more effective methods for treating cancer and other diseases, from diabetes and multiple sclerosis to arthritis and obesity.

(University of North Carolina at Chapel Hill) Just because scientific advances now allow individuals to learn their genetic make-up doesn't mean they should rush into genetic testing in hopes of making revolutionary improvements to their health, cautions a geneticist and practicing physician at the University of North Carolina at Chapel Hill.

(University of North Carolina at Chapel Hill) Researchers at the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill have discovered new targets for cancer treatment aimed at blocking a key step in tumor progression.

A review of cancer screening studies shows that white women who are obese are less likely than healthy weight women to get the recommended screenings for breast and cervical cancer, according to researchers at the University of North Carolina at Chapel Hill's School of Public Health.

A follow up study of participants in the Women's Health Initiative clinical trial led by a University of North Carolina at Chapel Hill researcher has found that women who were taking the combined hormone therapy of estrogen plus progestin may have an increased risk of cancer since the intervention was stopped, compared to participants in the trial's placebo group.